APA (7th ed.) Citation

Brahmer, J., & Steins, M. (2015). Nivolumab versus Docetaxel in advanced squamous-cell non-small-cell lung cancer. The New England journal of medicine, 373(2), . https://doi.org/10.1056/NEJMoa1504627

Chicago Style (17th ed.) Citation

Brahmer, Julie, and Martin Steins. "Nivolumab Versus Docetaxel in Advanced Squamous-cell Non-small-cell Lung Cancer." The New England Journal of Medicine 373, no. 2 (2015). https://doi.org/10.1056/NEJMoa1504627.

MLA (9th ed.) Citation

Brahmer, Julie, and Martin Steins. "Nivolumab Versus Docetaxel in Advanced Squamous-cell Non-small-cell Lung Cancer." The New England Journal of Medicine, vol. 373, no. 2, 2015, https://doi.org/10.1056/NEJMoa1504627.